BioDelivery Sciences International, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDSI research report →
Companywww.bdsi.com
BioDelivery Sciences International, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies.
- CEO
- Herm Cukier
- IPO
- 2002
- Employees
- 200
- HQ
- Raleigh, NC, US
Price Chart
Valuation
- Market Cap
- $577.05M
- P/E
- 6.80
- P/S
- 3.46
- P/B
- 3.07
- EV/EBITDA
- 11.71
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 85.98%
- Op Margin
- 22.27%
- Net Margin
- 50.90%
- ROE
- 57.33%
- ROIC
- 15.04%
Growth & Income
- Revenue
- $166.70M · 6.54%
- Net Income
- $84.86M · 230.05%
- EPS
- $0.82 · 215.38%
- Op Income
- $37.12M
- FCF YoY
- 62.70%
Performance & Tape
- 52W High
- $5.62
- 52W Low
- $2.50
- 50D MA
- $4.96
- 200D MA
- $3.88
- Beta
- 0.00
- Avg Volume
- 3.35M
Get TickerSpark's AI analysis on BDSI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 22, 22 | Watson W. Mark | sell | 54,740 |
| Mar 22, 22 | Watson W. Mark | other | 90,663 |
| Mar 22, 22 | Vollins James | sell | 282,055 |
| Mar 22, 22 | Vollins James | sell | 269,244 |
| Mar 22, 22 | Vollins James | sell | 43,334 |
| Mar 22, 22 | Vollins James | sell | 29,826 |
| Mar 22, 22 | Vollins James | sell | 82,508 |
| Mar 22, 22 | Vollins James | sell | 91,401 |
| Mar 22, 22 | Singh Vanila | sell | 17,019 |
| Mar 22, 22 | Singh Vanila | other | 35,851 |
Our BDSI Coverage
We haven't published any research on BDSI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BDSI Report →